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PERKHIDMATAN FARMASI KOMUNITI DI MALAYSIA : PERSPEKTIF 
DARI PENGAMAL PERUBATAN, AHLI FARMASI KOMUNITI, 
PENGGUNA DAN PIHAK BERKEPENTINGAN DALAM POLISI 
KESIHATAN 
 
ABSTRAK 
Peranan ahli farmasi komuniti telah berkembang di seluruh dunia. Dalam negara 
sedang membangun seperti Malaysia, peranan ahli farmasi komuniti dalam sistem 
kesihatan masih tidak jelas. Pada masa kini, penyelidikan dan data berkenaan 
perkhidmatan farmasi lanjutan seperti pengurusan terapi ubat, pengurusan penyakit 
kronik dan lain lain masih belum mencukupi. Untuk memajukan dan 
mempertingkatkan peranan ahli farmasi komuniti, pendapat-pendapat dari pihak 
berkepentingan perlu diambilkira. Tesis ini telah menyelidik pendapat orang yang 
terlibat (pengamal perubatan, ahli farmasi komuniti, pengguna dan pemegang 
kepentiangan dasar kesihatan) terhadap peranan farmasi komuniti dalam sistem 
kesihatan. Kaedah kualitatif dan kuantitatif telah digunakan dalam kajian ini. Untuk 
empat kajian kualitatif, tiga belas ahli farmasi komuniti, tiga belas pengamal 
perubatan, dua puluh satu pengguna dan tujuh pemegang kepentingan dasar 
kesihatan telah ditemubual. Analisis kandungan tematik digunakan untuk 
menganalisa data dan tema-tema utama termasuk: halangan untuk mempertingkatkan 
peranan profesional, trend amalan farmasi komuniti di Malaysia, pelaksanaan 
pengasingan pendispensan, kemudahan dan halangan untuk pengguna menerima 
peranan-peranan ahli farmasi komuniti sebagai pendidik kesihatan awam, pandangan 
xx 
!
pengamal-pengamal perubatan terhapadap amalan farmasi komuniti masa kini, 
pengetahuan dan kemampuan ahli farmasi komuniti dalam penyediaan perkhidmatan 
farmasi lanjutan, strategi untuk mengatasi halangan dan masa depan amalan farmasi 
komuniti di Malaysia. Berdasarkan hasil daripada kaedah kuantitatif, dua kaji selidik 
melalui pos telah dijalankan untuk menjelajah pengetahuan dan penyediaan ahli 
farmasi komuniti (n=395) dan pandangan pengamal-pengamal perubatan (n=205) 
terhadap perubahan amalan farmasi komuniti dalam Malaysia. Majoriti ahli farmasi 
komuniti (>70%) masih memberi tumpuan kepada kaunselling terhadap makanana 
tambahan, batuk dan selesema, dan kencing manis, menyediakan ujian tahap darah 
tinggi dan kencing manis.  Halangan kepada penghantaran perkhidmtan farmasi 
komuniti yang dikenal-pastikan termasuk kekurangan masa, kekurangan tenaga 
kerja, kekurangan kerjasama di antara ahli professional penjagaan kesihatan, 
kekangan undang-undang dan peraturan dan kekurangan keupayaan diri. Kajian ini 
juga mendapati secara umum, pengamal-pengamal perubatan menyokong 
penglibatan ahli farmasi komuniti dalam perkhidmatan farmasi lanjutan tetapi 
mereka tidak pasti tentang pengetahuan dan kemahiran ahli farmasi komuniti. 
Kebanyakan pengamal-pengamal perubatan menunjukkan mereka ingin 
berkerjasama dengan ahli farmasi komuniti untuk meningkatkan hasil terapeutik 
pesakit (~55%) dan rujikan pesakit daripada farmasi-farmasi komuniti untuk 
penilauian perubatan lanjut adalah dialu-alukan (~70%). Secara keseluruhan, tesis ini 
telah mengenalpasti penglibatan ahli farmasi komuniti dalam perkhidmatan farmasi 
komuniti, dari sudut pandangan pengamal perubatan, ahli farmasi komuniti, 
pengguna dan pemegang kepentingan dasar kesihatan. Halangan semasa terhadap 
transfomasi amalan farmasi komuniti dalam Malaysia telah dikenal-pastikan. 
Tindakan-tindakan termasuk perancangan, pembangunan dan pelaksanaan polisi baru 
xxi 
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adalah diperlukan Berdasarkan setiap faktor yang didapatkan dalam kajian ini, 
cadangan-cadangan telah diberikan untuk semua pihak berkepentingan utama 
termasuk ahli farmasi komuniti, penggubal-penggubal dasar kesihatan dan pihak 
berkuasa kerajaan bagi kemajuan and peningkatan profesion ini.  
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COMMUNITY PHARMACY SERVICES IN MALAYSIA : PERSPECTIVES 
FROM GENERAL PRACTITIONERS, COMMUNITY PHARMACY 
PRACTITIONERS, CONSUMERS AND HEALTH POLICY 
STAKEHOLDERS 
 
ABSTRACT 
Roles of community pharmacists (CPs) have evolved in many parts of the world. 
In developing countries such as Malaysia, little is known about the CPs’ role in 
the broader context of the healthcare system. At present, research on extended 
pharmacy services (e.g. medication therapy management, chronic disease  
management, etc) provided by CPs  in Malaysia remains scant. To effectively 
develop and implement strategies to enhance the role of CPs in Malaysia, it is 
important that the views of all the key stakeholders are explored. Accordingly, 
this thesis has explored the views of the general practitioners (GPs), community 
pharmacy practitioners (CPs), consumers and health policy stakeholders towards 
CPs’ extended roles in the Malaysian healthcare system. A triangulation of 
qualitative and quantitative methods was used in this study. For the four 
qualitative studies, thirteen CPs, thirteen GPs, twenty-one consumers and seven 
health policy stakeholders were interviewed. Thematic content analysis was used 
to analyse the data and the major themes identified included: barriers to enhancing 
professional roles, trends of community pharmacy practice in Malaysia, 
implementation of dispensing separation, facilitators and barriers for consumers to 
accept the roles of CPs as public health educators, perspectives of GPs on the 
xxiii 
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current community pharmacy practice, knowledge and ability of CPs towards the 
provision of extended pharmacy services, strategies to overcome the barriers, and 
future direction of community pharmacy practice in Malaysia. Based on the 
findings from the quantitative studies, two postal surveys were conducted to 
explore the knowledge and preparedness of CPs (n=395) and the perception of 
GPs (n=205) towards community pharmacy practice change in Malaysia. Majority 
of the CPs (>70%) were still focusing on counselling for nutritional supplement, 
cough and cold and diabetic, providing screening tests for blood pressure and 
blood sugar level. The identified barriers to the delivery of pharmacy services 
included lack of time, shortage of man power, lack of collaboration between 
healthcare professionals, legal and regulatory constraints and lack of self-efficacy. 
The study also found that in general, GPs were generally supportive towards the 
involvement of CPs in extended pharmacy services but they were uncertain about 
the knowledge and skills of CPs. Most of the GPs indicated that they would like to 
collaborate with community pharmacists on improving patient therapeutic 
outcomes (~55%) and welcome patient referral from community pharmacies for 
further medical evaluation (~70%).!In conclusion, this thesis has investigated the 
involvement of Malaysian community pharmacists in community pharmacy 
services, from the perspectives of GPs, CPs, consumers and health policy 
stakeholders. The current barriers towards the transformation of community 
pharmacy practice in Malaysia were identified. Future actions including planning, 
developing and implementing new policies are much needed. Based on the work 
of this thesis, sets of recommendations have been made for all the key 
stakeholders including CPs, policy makers and government authorities in order to 
bring re-professionalism and improvement to this profession.!
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CHAPTER  1 
GENERAL INTRODUCTION 
1.1  Background of the study  
Generally, community pharmacists are one of the most accessible, most available and 
frequently contactable healthcare providers (Claire, 1998). The roles of community 
pharmacists have evolved in many parts of the world. Over the last decade, globally, 
the pharmacy profession is moving from product-focused to a patient-oriented 
practice (Hassali et al., 2009b, Hasan et al., 2012).  Internationally, community 
pharmacists are recognised as healthcare professionals who have the knowledge and 
potential to deliver healthcare services beyond what they have traditionally provided 
such as medicine preparations and dispensing (Hasan et al., 2012, Saramunee et al., 
2014). Therefore, in comparison to the typical pharmacy services, extended 
pharmacy services within the community pharmacy setting in Malaysia 11are 
referred to services which are not associated with a pharmacist's traditional roles, 
such as dispensing and providing consultations on prescription and over-the-counter 
medications, but include new services such as, home medicines review (HMR), 
medication therapy management (MTM) and chronic disease management (CDM) 
(Cruthirds et al., 2013, Australian Pharmacy Council, 2013, Berbatis et al., 2007, 
Van et al., 2007).  Whilst developed countries have readily embraced this change, the 
progress has been much slower in developing countries. 
In Malaysia, general practitioners (GPs) can prescribe and dispense medication from 
their clinics. The absence of dispensing separation has limited the community 
pharmacist’s professional roles especially in the delivery of pharmaceutical care via 
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the dispensing process (Tarn et al., 2008, Che Awang, 2008). Under the Malaysian 
Poison Act 1952 (Section 7) and Poison Regulation 1952 (Regulation 3), private 
GPs’ clinics are given the right to dispense medication (Johnson and Bootman, 
1996). Accordingly, pharmacists' limited opportunity to dispense prescription 
medicines has driven community pharmacists in Malaysia to diverse their role into 
supplying health supplements and food, homecare, personal hygiene products and 
beauty products (Che Awang, 2008, George et al., 2010a, Wong, 2001). 
Consequently, community pharmacies could be perceived more as a “store for 
personal products” with community pharmacists as the drug suppliers or typical 
“store assistants” providing advice on the medication (Emily, 2006a). These 
pharmacists face challenges associated with acceptance or recognition of their 
professional services and the economics of providing pharmaceutical care (Hadida et 
al., 2001, Hassali et al., 2009b).  
As a developing and middle income country (The World Bank, 2014), Malaysia has 
established a vision of becoming a fully developed country by year 2020 (Vision 
2020) (Prime Minster's Office of Malaysia, 2014). To achieve this vision, significant 
changes in the practice of community pharmacy are needed.  In the recent 10th 
Malaysia Plan, the government has planned to reform the healthcare delivery system 
in the country (Ministry of Health Malaysia, 2013b). It is important to transform 
community pharmacy practice to be more professional and patient-oriented, in order 
to bring recognition and improvement to this industry.  However, baseline data to 
guide this change is scant. Indeed, existing legal requirements such as the absence of 
dispensing separation, have also impeded the speed of change in community 
pharmacy practice in Malaysia (Shafie et al., 2012).  
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1.2 Healthcare system in Malaysia 
Malaysia is a developing and middle income country with the updated population of 
30,093,412 on June 2014 (Department of Statistics Malaysia, 2014, The World Bank, 
2014). Malaysia’s healthcare system is basically operated in a two-tier system 
consisting of the public and private sector. The public healthcare system established 
in the early 1960s is funded by the government and financed mainly from taxes on 
earned income and provided services to everyone through a network of general 
hospitals, district hospitals & health clinics (Chee and Barraclaugh, 2007, Healy, 
2012). As of 2013, there were 140 public hospitals, 1025 health clinics including 
maternal and child health clinics, and 1831 rural/community clinics nationwide 
(Ministry of Health Malaysia, 2013b).  
The privatisation of healthcare services was implemented in the 1980s as an effort to 
reduce the government’s financial burden and has resulted an increase of private 
hospitals and clinics. The private sector provides health services on a non-subsidized, 
fee-for-service basis through a large network of private clinics and hospitals. As of 
2013, there were 209 private hospitals and 6675 registered private clinics nationwide 
(Ministry of Health Malaysia, 2013b). The private healthcare sector mainly caters for 
the urban population or those who can afford to pay. Private sector health 
expenditure is funded by private health insurance, managed care organizations, out of 
pocket spending by people, private corporations and non-profit institutions (Chee and 
Barraclaugh, 2007).   
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1.2.1 Vision and mission of Ministry of Health Malaysia  
Healthcare in Malaysia is mainly under the responsibility of the Malaysian 
government's Ministry of Health. The vision of the Ministry of Health is for 
Malaysia to be a nation working together for better health. Meanwhile, the Ministry 
of Health has a mission to lead and work in partnership for the people to fully attain 
their potential in health and to appreciate health as a valuable asset, to ensure a high 
quality health system, to emphasis on professionalism, caring, teamwork value, 
respect for human dignity and to promote community participation (Ministry of 
Health Malaysia, 2013a, Minitry of Health Malaysia, 2012).   
The!focus!of!the!ministry!is!now!more!extensive!especially!in!providing!equitable,!accessible!
and!quality!healthcare!facilities.!This!development!is!consistent!with!the!shift!of!pattern!in!
environmental!health,!health!technology!development!globally!and!liberally!pursuant!to!the!
changes! of! diseases,! health,! environment! and! technological! development! in! the! world!
(Ministry!of!Health!Malaysia,!2013a).!
!
1.2.2  Pharmacy practice in Malaysia 
According to Moullin et al, a professional pharmacy service should not be restricted 
to only being "delivered by a pharmacist", but we need to look beyond that, where 
also may be performed by "other health practitioner" (Moullin et al., 2013). The 
whole concept is demonstrated in the figure below (Figure 2.1):  
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Figure 1.1: Model of pharmacy service provision (Moullin et al., 2013) 
 
Pharmacy service in Malaysia came into existence in 1951 with the enactment of 
three main legislations governing its profession namely, the Registration of 
Pharmacist Act 1951, Poison Act 1952 and Dangerous Drug Act 1952. Prior to the 
independence, the pharmacy service in Malaysia was restricted primarily to the 
procurement, storage and distribution of drugs from the United Kingdom through the 
Crown Agents (2012).  
Following the independence, the pharmaceutical service in Malaysia has evolved to 
encompass regulating and ensuring quality, safety and efficacy of pharmaceutical 
products. The establishment of a Drug Control Authority (DCA) and its executive 
arm, National Pharmaceutical Control Bureau (NPCB) established under the Control 
of Drugs and Cosmetics Regulations 1984 gave rise to a more systematic 
pharmaceutical regulatory system (2012).  
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In the 1990’s, rapid expansion of pharmacy service was hampered by the shortage of 
pharmacists in the public workforce. Hence, in order to raise the number of 
pharmacists in the country to World Health Organization’s (WHO) recommended 
pharmacist to general population ratio of 1:2000 by year 2020, governments have 
taken measures to increase the number of local academic institutions offering 
undergraduate pharmacy degree. In addition, the Ministry of Health (MoH) and 
Pharmacy Board of Malaysia amended the pharmacist registration process in 2005 to 
include a period of 4 years (which reduced to 2 years in 2011 and to 1 year in 
2013/14) mandatory government service by pharmacists in order to retain sufficient 
manpower in the public sector. The increase in the number of pharmacists in the 
public sector had allowed the establishment and expansion of clinical pharmacy 
service within the MoH. In 2012, there are 11,240 registered doctors working in 
private sector in Malaysia (Ministry of Health Malaysia, 2013b). In the pharmacy 
sector, there are 3744 registered pharmacists working in private sector and 
approximately 1800 community pharmacies in the country (Ministry of Health 
Malaysia, 2014, Ministry of Health Malaysia, 2013b).   
Currently, dispensing separation is not practiced in Malaysia and private doctors are 
allowed to prescribe and dispense medications. The current scenario is that 
consultation, treatment and medicines costs are charged separately in private 
hospitals and clinics. The patients pay only for the medication cost when they visit a 
community pharmacy as pharmacist consultation and dispensing services are free of 
charge.   
Community pharmacies are premises with at least one pharmacist holding a Type A 
license issued under the Poison Act 1952. The Type A license allows an individual to 
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supply poison either by retail only or by both retail and wholesale (Laws of 
Malaysia). For all community pharmacies, the executive board and share equity shall 
be represented by pharmacists (Ministry of Health Malaysia, 2011). Community 
pharmacy benchmarking guideline has been introduced and revised from time to time 
by the MoH to provide an overview of the requirements that community pharmacies 
are expected to fulfil in the area of infrastructure, equipment, personnel and practice 
(Ministry of Health Malaysia, 2011). According to the proposed guidelines, the key 
areas that are benchmarked include premises, equipment, personnel, dispensing of 
medicines, dispensing errors, inventory management, reference library, professional 
standards and participation in health promotion activities (Malaysian Pharmacutical 
Society). The details of the benchmarking guidelines are available on Malaysian 
Pharmaceutical Society 1  website (http://www.mps.org.my) (Malaysian 
Pharmacutical Society).  
 
1.2.3 Role of community pharmacists in Malaysia 
Due to the absence of dispensing separation, the healthcare system has limited the 
community pharmacist's professional roles including the provision of pharmaceutical 
care and quality use of medicines (Tarn et al., 2008, Che Awang, 2008). The 
pharmacists were found well-trained and underutilized (Shafie et al., 2012, Chua et 
al., 2013).     
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! !!!!!!!!!!!!!!!!!!!!
1 Malaysian Pharmaceutical Society (MPS) is an official national association for pharmacists in 
Malaysia.  
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In Malaysia, the primary role of pharmacists is in the supply of Group C poisons in 
the 1952 Poison Act. Group C poisons are medicines dispensed by registered 
pharmacists in a licensed pharmacy premise without a prescription (Laws of 
Malaysia). The limited role in dispensing prescription medicines (Poison Group B) 
due to absence of dispensing separation, has diverted the pharmacists' role into 
supplying health supplements and foods, homecare, personal hygiene products and 
beauty products (Wong, 2001, Che Awang, 2008, Hassali et al., 2009b). Community 
pharmacists in Malaysia have limited opportunity to optimise their clinical 
knowledge and role. Community pharmacies are functioning much like a personal 
store while community pharmacists are seldom involved in primary health care, but 
instead, as drug sellers or typical “assistant” providing advices on the medication 
(Anonymous., 2008).  
 
1.2.4 Challenges and future direction of community pharmacists 
Currently, community pharmacists in Malaysia are facing challenges from an 
economic and professional perspective. The profession is at a crossroad and need to 
decide which path it takes to secure its future. The role of community pharmacists in 
Malaysia remains to be fully defined or charted. Whilst community pharmacists in 
Malaysia are equipped with healthcare knowledge and have been trained as  
healthcare professionals, under the healthcare system of this country and in the 
absence of dispensing separation and the presence of current challenges, their 
knowledge and skills were fully utilised (Shafie et al., 2012).   
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In 2007, the National Medicines Policy stated that quality use of medicines, 
prescribing and dispensing functions must be separated (Ministry of Health 
Malaysia., 2007). Nevertheless, strong oppositions of the implementation of 
dispensing separation have been constantly received from Malaysian Medical 
Association (MMA) and consumers (Hassali et al., 2009d). The shortage of 
community pharmacists and the possibility of increase in patients’ health expenditure 
were the common reasons for the parties to object the separation of prescribing and 
dispensing in Malaysia (Hassali et al., 2009b). One of the main reasons for delaying 
the implementation of dispensing separation is the objection by medical practitioners 
(Azhar et al., 2009). The relationship and collaboration between pharmacists and 
general practitioners need to be enhanced and improved for the benefit of the patients.  
Community pharmacists must ensure that they are well-equipped and prepared in 
terms of updated knowledge by attending continuing professional education (CPE) 
and willing to work with other healthcare practitioners as a team.  
An issue that has been raised recently among community pharmacists is the poor 
distribution of pharmacies in the country. There are sufficient community pharmacies 
in the city however, there is an insufficiency of community pharmacies in small 
towns and rural places (Wong, 2001). Besides, The phenomenon of "price war" 
among community pharmacies and between private clinics and community 
pharmacies have also brought great negative impact to the profession (Hassali et al., 
2010a). Due to the absence of price control and regulations in Malaysia, this 
unhealthy business competition has been undercutting the price of pharmaceutical 
products and the focus of community pharmacists have been shifting from patient-
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oriented practice back to product-oriented in order to strive for survival (Hassali et 
al., 2013, Hassali et al., 2010b).  
Despite all the mentioned challenges, a key challenge faced by the community 
pharmacists in Malaysia is whether they are ready for a change with respect to the 
breadth and depth of pharmacy services being provided or type of pharmacy practice 
being delivered. Rosenthal M mentioned in a commentary that ultimately the 
traditional culture or mind-set of the pharmacists has to be renewed and changed 
(Rosenthal et al., 2010). In the present, a few areas of pharmacy practices in 
Malaysia requires development or further refinement viz. benchmark, pharmacy 
premise benchmark, computerised pharmacy operation, appropriate and effective use 
of medicines, patient medication records, medicine prices control and continuing 
professional development (Chong, 2010).  Efforts are much needed within the 
profession in order to understand the lack of advancement in pharmacy practice.  
 
1.3 Justification of the study 
With the absence of dispensing separation and all the challenges faced by community 
pharmacists, transformation of the community pharmacy practice is essential. Such 
change will need to include improvements in pharmaceutical care provided by the 
community pharmacies. Accordingly, community pharmacists have a pivotal role to 
play in transforming their current practice which is product-oriented to a patient-
centred service provision. 
1. At present, research and data on the provision of community pharmacy 
services in Malaysia remain scant. Indeed, it can be challenging to generalise 
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data from developed countries to those in the middle income regions due to 
the variations in healthcare system, resources and way of life in these 
different economic regions.  
2. There is scant information on the readiness of community pharmacists in 
Malaysia towards professional practice change under the proposed healthcare 
reform presented to the nation in 2011 by the Malaysian government.  
3. To effectively develop and implement strategies to enhance the role of 
community pharmacists in Malaysia, it is important that the views of all the 
key stakeholders and consumers are explored. However, such data are not 
available. Without these data, it is difficult to develop and implement policy 
to facilitate the change.  
Accordingly, this thesis has been designed to explore the perceptions of the general 
practitioners, community pharmacy practitioners, consumers and health policy 
stakeholders towards community pharmacists’ professional roles and the provision of 
community pharmacy services in the Malaysia. This work has provided much needed 
baseline data to facilitate the future direction of community pharmacy practice in 
Malaysia. 
 
1.4  Aims and objectives 
The overall aim of this study was to investigate the involvement of Malaysian 
community pharmacists in community pharmacy services, from the perspectives of 
general practitioners, community pharmacy practitioners, consumers and health 
policy stakeholders.  
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The objectives were:- 
1. To explore the perceptions of community pharmacists towards the need for 
practice change to improve community pharmacy profession in Malaysia.  
2. To determine the knowledge and attitudes of community pharmacists in Malaysia 
towards their professional roles in community pharmacy practice.  
3. To document the current patient-oriented services provided by community 
pharmacists.  
4. To explore the perceptions of general practitioners towards the provision of 
extended pharmacy services provided by community pharmacists and their 
willingness to collaborate in these services.  
5. To explore the perceptions and knowledge of consumers towards the professional 
roles of community pharmacists. 
6. To explore the perceptions among the policy makers in Malaysia towards the 
provision of extended pharmacy services provided by community pharmacists 
and the future of this profession.  
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1.5 Thesis overview  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Perceptions towards the involvement of Malaysian 
community pharmacists in community pharmacy services 
 
Qualitative Phase 
- Interviews 
!
Quantitative Phase 
- Questionnaire surveys 
D Community!Pharmacists!
D General!Practitioners!
D Consumers!
D Health!Policy!
Stakeholders!
D Community!Pharmacists!
D General!Practitioners!
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CHAPTER  2 
LITERATURE REVIEW 
2.1 Introduction 
This chapter reviews the literature relevant to this study. It provides an in-depth 
review of the literatures relevant to this thesis. It demonstrated the current trend of 
pharmacy practice around the globe and the perceptions of community pharmacists, 
general practitioners and consumers towards the current practice.  
Over the last decades, changes in world's demographical, socio epidemiological 
disease pattern and health services provision have made the pharmacist’s role in the 
public health workforce more eminent (Adepu and Nagavi, 2006). The concept of 
"Pharmaceutical care", which involves a responsibility on the part of the pharmacist 
for patients' drug-related needs (Krska and Veitch, 2001b),  has refined the 
traditional images of pharmacies and the roles and perception of pharmacists (Hepler 
and Strand, 1990).  
According to Moullin et al (Moullin et al., 2013), a professional pharmacy service is 
defined as "an action or set of actions undertaken in or organised by a pharmacy, 
delivered by a pharmacist or other health practitioner, who applies their specialised 
health knowledge personally or via an intermediary, with a patient/client, population 
or other health professionals, to optimise the process of care, aiming to improve 
health outcomes and the value of healthcare" (p. 2). Community pharmacists are 
well-placed to deliver a professional service as they are often the first point of 
contact in the healthcare system (Adepu and Nagavi, 2006).  Pharmacists have been 
shifting their practice from a 'product-focused' function of dispensing and 
15 
!
distribution of medication to a professional healthcare practice which is 'patient-
oriented' where pharmacists are involved directly in providing advice, care, 
counselling and pharmacy services (Bryant et al., 2009b). Schommer JC et al 
reported that in 2004, pharmacists in the United States spent 49% of their working 
hours dispensing drugs and 32% of their time on providing healthcare services, such 
as evaluating the safety of drug therapy, advising patients on drug therapies, 
administering vaccines and counselling patients on services ranging from self-care to 
disease management. Furthermore, it was mentioned that the pharmacists would like 
to decrease their time spent on dispensing to only 39% and increase the time spent on 
providing healthcare services to 48% of their working hours daily (Schommer et al., 
2006).    
In addition, community pharmacists have an increasing role in making a positive 
contribution to public health (Eades et al., 2011). In order to fulfil the missions of 
public health, which are to "fulfil society's interest in assuring conditions in which 
people can be healthy" and "promote physical and mental health and preventing 
disease, injury, and disability" (Andy, 2006), community pharmacists are exploring 
opportunities to offer and provide more public health activities, such as substance 
misuse services, immunisation scheme, asthma-management schemes, advice on 
men's health and services on the safe and effective use of medicines (Eades et al., 
2011).  
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2.2 Current international trend of pharmacy practice 
The profession’s shift to a patient-centred practice sees community pharmacy 
practice shifting from manufacturing, compounding, and distribution of 
pharmaceuticals to the provision of clinical services, pharmaceutical care, and 
cognitive pharmaceutical services (Roberts et al., 2008). Within the context of 
practice-change, Hepler and Strand redefined the responsibilities of the pharmacist 
and pharmacy services in 1990, by applying the term "pharmaceutical care" to this 
new concept of pharmacists' services (Hepler and Strand, 1990). An updated 
definition describes pharmaceutical care as "a patient-centred practice in which the 
practitioner assumes responsibility for a patient's drug-related needs and is held 
accountable for this commitment" (p. 622) (McGivney et al., 2007). More recently, 
"cognitive pharmaceutical services (CPS)" was introduced to the pharmacy 
profession, including both hospital and community pharmacists. CPS is referred to as 
professional services provided by pharmacists, using their skills and knowledge to 
take an active role in contributing to patient's health through effective interaction 
with both patient and other health professionals (Roberts et al., 2006).  
As the roles of pharmacists have been transforming to a healthcare professional who 
is involved directly in patient care services (Hassali et al., 2009b, Bryant et al., 
2009b), many developed countries such as Australia, the United States and the 
United Kingdom have also started to recognise the changing roles of the community 
pharmacist as an expert in the provision of healthcare (George et al., 2010b). 
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2.2.1 Current trend in developed countries 
In Australia, the pharmacy profession has significantly shifted from a product 
oriented practice to a service- and patient-centred practice (Roberts et al., 2005). The 
involvement of pharmacists in the concept of pharmaceutical care, clinical services 
and cognitive pharmaceutical services (CPS) have brought transformation to the 
traditional roles of pharmacists (Roberts et al., 2008). In Australia, the five year 
Community Pharmacy Agreement between the Australian Government and the 
Pharmacy Guild of Australia was introduced in 2010 with the objectives to provide 
consumers with quality pharmacy services, to expand community pharmacist's 
professional roles, and others (The Commonwealth Department of Health and 
Ageing, 2000).  Professional practice programs including Residential Medication 
Management Review2 (RMMR), Home Medicines Review3 (HMR),  medicines 
information to consumers (Consumers Medicines Information), and quality care 
pharmacy program4 (QCPP) were included since year 2000 in the Third Community 
Pharmacy Agreement (2000-2005) (The Commonwealth Department of Health and 
Ageing, 2000). According to a systemic review of professional pharmacy services 
published in Australia, community pharmacy services in Australia can be broadly 
divided into 6 main categories, including the provision of drug information, 
provision of pharmacy and pharmacist-only medicines, clinical interventions, 
medication management services, preventive care services for patients with chronic 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! !!!!!!!!!!!!!!!!!!!!
2 A Residential Medication Management Review (RMMR) is a services conducted by an accredited 
pharmacist when requested by a resident's GP and undertaken in collaboration with the resident's GP 
and appropriate members of the resident's healthcare team.    
3  The Home Medicines Review (HMR) programme is undertaken through a comprehensive 
medication review medication review conducted by an accredited pharmacist in the patient's home.   
4 Quality Care Pharmacy Program (QCPP) is a quality assurance program for community pharmacy, 
and provides support and guidance on professional health services and pharmacy business operations.!!!
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conditions and participating in therapeutic decisions (Benrimoj and Roberts, 2005, 
Roughead et al., 2003). Roles of community pharmacists in medication and disease 
management, especially in the management of asthma, hypertension, diabetes and 
bodyweight have been reported with positive clinical and economic impact data 
(Emmerton et al., 2012). Being one of the providers of Pharmacy Asthma 
Management Service (PAMS) has created an opportunity for the community 
pharmacists to be involved in innovative service delivery models and community 
pharmacists were trained and empowered as research partners (Emmerton et al., 
2012). The involvement of community pharmacists in Australia in the prevention and 
management of cardiovascular disease have significantly brought improvement in 
clinical markers, quality of life, satisfaction for general practitioners, pharmacists and 
consumers, and also in terms of cost-effectiveness (George et al., 2011).  The 
extended roles being performed included the provision of education materials, 
monitoring and screening of conditions, offer intervention in areas such as smoking 
cessation, medicines management, medicine compliance, and lifestyle modification 
(George et al., 2011).  
In the United Kingdom (UK), the government is creating opportunities for 
community pharmacists to be more involved in delivering National Health Service 
(NHS) services that promote self care and improve the management of long term 
conditions (David, 2004). One of the major developments in the role of pharmacists 
in the UK was the introduction of independent or supplementary prescribing by 
pharmacists (David, 2009). This change aimed to fully utilise the skills, knowledge 
and specialization of pharmacists and subsequently to develop a more flexible system 
for prescribing, supplying and the administration of medicines (Tonna et al., 2007). 
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More recently, the new medicine services (NMS) was introduced by National Health 
Service (NHS) in United Kingdom to the community pharmacists. NMS is an 
advanced pharmacy service provided by community pharmacists to patients. It 
targets patients with primarily long term conditions (e.g. asthma, type 2 diabetes, 
hypertension, antiplatelet/anticoagulant therapy and chronic obstructive pulmonary 
diesa where new medicines have been prescribed and aims to improve medicine 
adherence, increase patient engagement with their condition and medicines, reduce 
hospital admissions due to adverse reactions associated with medicines, and others 
(Royal Pharmaceutical Society of Great Britain, 2014b). Another new concept that 
was launched in June 2014 is ‘medicines optimisation’. ‘Medicines optimisation’ 
aims to ensure the right choice of medicine, at the right time. It was developed and 
promoted by Royal Pharmaceutical Society of Great Britain, by in collaboration 
between patients and the health professional that care for them. In the area of 
pharmacy profession, pharmacists including community pharmacists need to adopt 
the principles to improve the prescribing, dispensing, administering or taking of 
medicines (Royal Pharmaceutical Society of Great Britain, 2014a). Several barriers 
have been identified along the way (Hobson and Sewell, 2006), but yet it is believed 
that this change will continue to bring positive impact to the UK healthcare system.  
In Canada, the vision of pharmacists outlined in the Blueprint for Pharmacy, is to 
provide "optimal drug therapy outcomes for Canadians through patient-centred care" 
(Canadian Pharmacists Association, 2008). The profession aims to shift from 
traditional dispensing duties to services that will bring improvement in patient 
outcomes (Rosenthal et al., 2010). Community pharmacists have been taking a more 
proactive role in establishing their place in the primary care system to fulfil the needs 
20 
!
of Canadians and achieve the vision for pharmacy and focusing on the strategy of 
consultation (2009). Rosenthal et al described in a commentary that the pace of 
pharmacy practice change in Canada has been slow. Barriers to change have been 
identified previously but the authors highlighted that the biggest barrier has been 
observed and believed to be pharmacists themselves. The term pharmacist "personal 
traits" was used and it was related to patient care. "Personal traits" included lack of 
confidence, fear of new responsibility, paralysis in the face of ambiguity, need for 
approval and risk aversion (Rosenthal et al., 2010).  Mak VSL et al reported that in 
Australia, community pharmacists lacked of awareness and appreciation towards 
healthcare reforms in the country; and they were not well-prepared to contribute to 
the new model of practice (Mak et al., 2012). The Self-Efficacy model (Bandura, 
1986) was found to be important and useful in scenario like this (Mak et al., 2012). 
In order to bring changes, people have to believe that they have the knowledge and 
skills to change. Along the changing process, community pharmacists need guidance, 
facilitation and a model of practice that they are convinced and believed that they can 
adopt (Bandura, 1986).    
In the United States (US), pharmacists have been playing important and pivotal roles 
in transforming the healthcare system. According to Ried LD and Posey LM, 
pharmacists in the US have been increasing their time spent in providing healthcare 
services, including advising, evaluating and counselling on drug therapies and safety 
use of medications, and so on (Ried and Posey, 2006). Besides, it was reported by 
Mott DA et al that there was an increase in recognition of the US government 
towards the importance of clinical pharmacy services in patient care and the 
government has implemented pharmacy programs to enhance patient-oriented care in 
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the country, including patient counselling and the utilisation-review activities (i.e. 
activities involving precertification, concurrent review, discharge planning and case 
management) (David et al., 2006). The appointment made by the Centers for 
Medicare and Medicaid Services (CMS) for pharmacists as one of the health 
professionals to provide medication therapy management (MTM) has proven the 
recognition by the government towards the ability of pharmacists (Centers of 
Medicare and Medicaid Services, 2014). MTM was a program implemented for the 
benefit of the elderly and the goals are to optimise therapeutics outcomes and to 
reduce the risk of adverse events through improved medication use. As one of the 
providers, pharmacists may offer services such as patient education and monitoring 
to improve the effectiveness and safety of medication use, and to increase patient 
compliance leading to better therapeutic outcomes (Law et al., 2009). Another 
positive scenario was the involvement of pharmacists in the US towards the 
management of blood pressure (BP) control. According to a study done by Margolis 
KL et al (2013), home BP telemonitoring with pharmacist management and 
intervention has resulted significant improvements in BP control. Within this 
program, pharmacists met with patients for the first time for 1-hour for explanation 
and reviewing of the high BP condition, subsequent follow ups were then carried out 
through telephone. This program has also improved patient satisfaction and shown 
cost-effectiveness (Margolis et al., 2013).  
 
2.2.2 Current trend in developing countries 
The situation of pharmacy practice in developing countries are generally more 
product-oriented, rather than patient-oriented (George et al., 2010b). In many 
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developing countries, pharmacists have much more to offer in terms of healthcare 
services than what they have been providing traditionally (Hasan et al., 2012); the 
pharmacists’ skills and knowledge in healthcare are not utilised to benefit their 
community. A systematic review on the quality of private pharmacy services in low 
and middle-income countries, such as Vietnam, India, Lao PDR, Thailand, Nepal, 
Nigeria, Uganda, Egypt, Ghana Gambia, Ethiopia, Zimbabwe, Brazil and Mexico 
was conducted by Smith F (Smith, 2009). Smith F concluded that the quality of 
professional services provided by the pharmacies are limited, although local 
pharmacies played an important part in the provision of healthcare services for many 
people (Smith, 2009). The major challenges in the healthcare delivery system within 
these low and middle income countries included the lack of a trained health 
workforce and the issue of medicine supplied without a prescription. The author 
suggested that the governments should regulate practice to promote higher standards 
or care and the barriers to provision of higher quality of healthcare need to be 
identified and overcome (Smith, 2009).   
In countries like India and Nepal, pharmacists are trained more towards 
manufacturing of pharmaceuticals and limited pharmacists are involved in patient-
oriented activities, especially outside healthcare institution in community setting 
(Subal and Dondeti, 2009, Azhar et al., 2009). The is due to the high demand from 
the industrial sector and pharmacy curriculum in universities which focus mainly on 
subjects related to the aspects of pharmaceutical production (Azhar et al., 2009).  
In the United Arab Emirates (UAE), findings reported that there was a lack in the 
provision of services among the pharmacy practice (Hasan et al., 2011). Many 
professional healthcare services are not being offered and provided by majority of 
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the pharmacies (Hasan et al., 2012). Pharmacists were aware of the trend of patient-
oriented practice, but the practice change has been slow due to barriers such as the 
lack of pharmacists' skills, resources and time, low perception of the community 
towards the pharmacy profession, pharmacists are acknowledged as business people 
rather than health professionals and minimal pharmacist-patient interaction due to 
low patient demand. Sanah Hasan et al suggested that identifying factors and 
strategies that will bring improvement to the quality of community pharmacy 
services in UAE are needed (Hasan et al., 2011).  
In Pakistan, there was a lack of pharmacy services in hospital and community 
pharmacies because of the isolation and the lack of recognition of pharmacists as 
healthcare professionals by the public and also other health practitioners. The main 
reason for the lack of recognition of pharmacists were mainly due to the 
insufficiency of pharmacists in public health services among the community 
pharmacies, which lead to the absence of interaction between pharmacists and other 
health professionals and with the public. At such, pharmacists’ roles are limited to 
drug delivery, procurement and inventory control (Azhar and et. al., 2009). 
In Saudi Arabia, community pharmacists play an important role in patient 
counselling and provide basic drug information, such as appropriate drug usage, 
dosage, side effects, and so on, but they have a limited clinical role in the dispensing 
of medication (Al-Hassan, 2009a). In addition, there was a lack in pharmaceutical 
care practice by community pharmacists in Saudi Arabia due to the concerns of 
community pharmacists towards their clinical knowledge, communication skills and 
pharmacy layout (Mohammed et al., 2007). Literature suggested that pharmacists in 
the community should be trained in an appropriate fashion to meet the goals in 
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promoting patient health care (Al-Hassan, 2009b). Besides, a study done by Al-
Ferihi et al reported that there was a lack of adherence of community pharmacists to 
the regulations governing the dispensing of drugs (Alfreihi et al., 1987). This finding 
was further supported by Bawazie SA, in which community pharmacists were found 
dispensing prescription drugs including antibiotics, cardiovascular drugs and topical 
potent corticosteroids over the counter without a prescription. The studies suggested 
the need of strict enforcement on the regulations governing the sale of drugs, and the 
need to introduce changes to present community pharmacy practice (Bawazir, 1992).  
In Africa, for example in Greater Accra, there is a serious shortage of pharmacists in 
the country. It has been reported that there were only 619 pharmacists serving 2.9 
million people in the country (WHO recommendation 1:2000) (Azhar et al., 2009). 
In Ghana, the majority of community pharmacists are located in the city and thereby 
causing an unequal distribution of services across the country. The shortage of 
pharmacists in many parts of the country has affected the quality of health-care 
services (Smith, 2004). In  South Africa, the maldistribution of community 
pharmacies and pharmacists had limited their accessibility to the majority of the 
population. Most of the community pharmacists were located in the more developed 
provinces, while very few were serving in the rural area (Gilbert, 1998).   
 
2.2.3 Perception of community pharmacists towards the current practice 
As mentioned in Chapter 1, one of the objectives of this study was to explore the 
perceptions of community pharmacists towards the need for community pharmacy 
practice-change to improve the public healthcare system. While the pharmacy 
